NEUROLOGY 2003;61: [1373] [1374] [1375] [1376] [1377] The increasing prevalence of multiple sclerosis (MS) noted in repeated epidemiologic studies was previously assumed to be secondary to migration, population age structure, improved case ascertainment on restudy, and increased survival. 1 Some have questioned these assumptions and suggested that the increasing prevalence was due in part to increased incidence. 2 Areas with repeated epidemiologic surveillance have had varied results; areas with relatively high initial incidence rates tend to remain stable, whereas those with low initial rates, such as in Southern Europe, tend to show increasing rates over time. 3 Methods. All cases of MS diagnosed in Olmsted County, MN, from 1985 to 2000 were identified using the centralized diagnostic index at the Mayo Clinic and the Rochester Epidemiology Program Project, a shared database of all medical practitioners in the county. The rural makeup of all surrounding counties and regional physician referral patterns nearly ensures complete case ascertainment. Incident cases were required to have established residency at least 1 year prior to diagnosis of MS, effectively eliminating patients who had migrated for medical care. Two neurologists (W.T.M. and S.P.) reviewed each chart. Cases were categorized as clinically definite, laboratory-supported definite, clinically probable, and laboratory-supported probable per the criteria as defined by the 1983 "New diagnostic criteria for MS: guidelines for research protocols." 4 Patients with isolated optic neuritis were excluded. The diagnostic criteria and inclusion/ exclusion criteria were chosen because previous researchers studying the same population had used them, thus enabling direct comparison of our data to theirs.
Data regarding basic demographic characteristics, age at onset, age at diagnosis, and follow-up status were abstracted from the medical record of each patient. The patients were interviewed personally or contacted by telephone to confirm demographic and disease-related information. The date for the prevalence study was December 1, 2000. The population data were obtained from the US Census Bureau, US Census 2000, and indicate that the population is predominantly middle class and white. The majority of prevalence cases received their medical care at Mayo Clinic; the remaining received their care through the Olmsted Medical Group or the Olmsted Community Hospital.
Statistical methods. Incidence and prevalence rates for MS were calculated with the use of population denominators interpolated between census years. These calculations used an in-house SAS macro developed for this purpose. 5 We assumed that the incidence cases follow a Poisson distribution to estimate standard errors for these rates.
In order to examine trends over time, we age-and sex-adjusted to the 1950 US white population to compare incidence rates with previously published data. Age-and sex-adjusted rates for a par- (table 2) . The crude annual incidence rates were 4.5/100,000 for men, 10.4/100,000 for women, and 7.5/100,000 overall. When age-and sexadjusted to the 2000 US white population, the overall annual incidence rate was 7.3/100,000 (95% CI, 6.0 to 8.6), and to the 1950 US white population, 7.1/100,000 (95% CI, 5.9 to 8.3). Age and sex adjustment to the 1950 US white population is relevant when comparing these results with those of previous reports on the same geographic population, which were similarly adjusted (table 3) . 2 The median age at diagnosis was 37.2 years (range 16. Distribution of category of MS diagnosis as outlined in the criteria set forth by the 1983 "New diagnostic criteria for MS: guidelines for research protocols" is shown in table 4. 4 A total of 78% were classified as having clinically definite MS (CDMSA1 or 2) and 88.6% as either clinically or laboratory-supported definite MS (CDMSA1, 2, LSDMSB1, 2, or 3). Only 9.9% were classified as clinically probable MS (CPMSC1, 2, or 3) and 0.8% as laboratory-supported probable MS (LSPMSD1). This high percentage of clinically definite cases is most likely related to the evolution of disease over a long median follow-up period. The distribution by diagnostic category has changed minimally compared to previous categorization of the same population in 1985. 2
Discussion. We compared our results to others with both incidence and prevalence data, which provide the most complete epidemiologic profile of MS. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Compared to other incidence and prevalence population-based studies, our raw incidence rate of 7 (table 5) . 15, 21 A comparison of our results to the previous study of the same geographic population indicates an increase in crude prevalence from 159.8/100,000 in 1985 to 176.6/100,000 in 2000. However, there is a decline in prevalence when both rates are age and sex adjusted to the 1950 US white population-from 170.8/100,000 in 1985 to 159.8/100,000 in 2000. This apparent reversal is due to changes in the age distribution of the population between 1950 and 2000; the 1985 population was younger than the 1950 population, and the 2000 population was older than the 1950 population (figure 1). Although adjustments for age and sex have not been uniformly applied in other studies, controlling for such changes in the population structure may increase the accuracy of the data, especially when making historical comparisons.
Although there was an increase in the prevalence rate from 46/100,000 in 1915 to 108/100,000 in 1978, the rate now appears to be stable. 26, 27 Previously, the increasing prevalence in the county was thought to have been partly due to an increasing incidence of MS. 2 However, the apparent upward trend in the incidence of MS has not been sustained (see table 3 and figure 2). Improved case ascertainment through increased medical documentation, technology, and testing likely explains the apparent increasing incidence through the 1970s and stabilization since that time. Furthermore, the recent shift of the population age structure toward a greater proportion of the elderly likely stabilizes and may even decrease the incidence rate. We plan further epidemiologic studies of this population to evaluate the possibility of future changes in incidence and prevalence.
